Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Auxly Announces Listing of Warrants


Posted on: 27 Jul 18

VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (the "Company") is pleased to announce that it has received the approval of the TSX Venture Exchange ("TSXV") for the listing of 32,200,000 common share purchase warrants (the "Warrants") of the Company on the TSXV as a supplemental listing. The Warrants were issued pursuant to a debenture unit offering of the Company completed on January 16, 2018. The Warrants are expected to commence trading on the TSXV under the symbol "XLY.WT.A" at the open of the market on July 30, 2018.

Each Warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of $1.80 per share at any time prior to 4:00 p.m. (Toronto time) on January 16, 2020. The Warrants are governed by a warrant indenture between the Company and Computershare Trust Company of Canada dated July 24, 2018.

ON BEHALF OF THE BOARD

"Chuck Rifici" Chairman & CEO

About Auxly Cannabis Group Inc. (TSX.V: XLY)

Auxly Cannabis Group is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.

Investor Relations:
For more information about investing in Auxly Cannabis Group, please visit: http://www.auxly.com or contact our Investor Relations Team:
Email: IR@auxly.com
Phone: 1-833-695-2414

Stay Connected:
Follow up on Twitter @Auxlygroup

Media Enquiries (only):
For media enquiries or to set up an interview please contact:
Sarah Bain, VP External Affairs
Email: sarah@auxly.com
Phone: 613.230.5869

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

GlobeNewswire
globenewswire.com

Last updated on: 27/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.